JP2021512601A5 - - Google Patents

Info

Publication number
JP2021512601A5
JP2021512601A5 JP2020541862A JP2020541862A JP2021512601A5 JP 2021512601 A5 JP2021512601 A5 JP 2021512601A5 JP 2020541862 A JP2020541862 A JP 2020541862A JP 2020541862 A JP2020541862 A JP 2020541862A JP 2021512601 A5 JP2021512601 A5 JP 2021512601A5
Authority
JP
Japan
Prior art keywords
aav
seq
sequence
capsid protein
pharmaceutical composition
Prior art date
Application number
JP2020541862A
Other languages
English (en)
Japanese (ja)
Other versions
JP7066861B2 (ja
JP2021512601A (ja
JPWO2019152841A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/016351 external-priority patent/WO2019152841A1/en
Publication of JP2021512601A publication Critical patent/JP2021512601A/ja
Publication of JPWO2019152841A5 publication Critical patent/JPWO2019152841A5/ja
Publication of JP2021512601A5 publication Critical patent/JP2021512601A5/ja
Priority to JP2022073374A priority Critical patent/JP7433360B2/ja
Application granted granted Critical
Publication of JP7066861B2 publication Critical patent/JP7066861B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020541862A 2018-02-01 2019-02-01 Pah遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法 Expired - Fee Related JP7066861B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022073374A JP7433360B2 (ja) 2018-02-01 2022-04-27 Pah遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862625150P 2018-02-01 2018-02-01
US62/625,150 2018-02-01
PCT/US2019/016351 WO2019152841A1 (en) 2018-02-01 2019-02-01 Adeno-associated virus compositions for pah gene transfer and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022073374A Division JP7433360B2 (ja) 2018-02-01 2022-04-27 Pah遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法

Publications (4)

Publication Number Publication Date
JP2021512601A JP2021512601A (ja) 2021-05-20
JPWO2019152841A5 JPWO2019152841A5 (https=) 2022-02-09
JP2021512601A5 true JP2021512601A5 (https=) 2022-02-09
JP7066861B2 JP7066861B2 (ja) 2022-05-13

Family

ID=67478560

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020541862A Expired - Fee Related JP7066861B2 (ja) 2018-02-01 2019-02-01 Pah遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法
JP2022073374A Active JP7433360B2 (ja) 2018-02-01 2022-04-27 Pah遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022073374A Active JP7433360B2 (ja) 2018-02-01 2022-04-27 Pah遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法

Country Status (14)

Country Link
EP (1) EP3746113A4 (https=)
JP (2) JP7066861B2 (https=)
KR (2) KR102528641B1 (https=)
CN (1) CN111886021A (https=)
AU (1) AU2019215150A1 (https=)
BR (1) BR112020015511A2 (https=)
CA (1) CA3089824A1 (https=)
CL (1) CL2020001992A1 (https=)
CO (1) CO2020010783A2 (https=)
EA (1) EA202091844A1 (https=)
IL (2) IL295830A (https=)
MX (1) MX2020008085A (https=)
PE (1) PE20210341A1 (https=)
WO (1) WO2019152841A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20190401A1 (es) 2016-07-26 2019-03-13 Biomarin Pharm Inc Novedosas proteinas de la capside del virus adenoasociado
BR112020022722A8 (pt) 2018-05-09 2022-01-18 Biomarin Pharm Inc Genoma e seu uso, vetor, partícula, molécula de ácido nucleico isolada, ácido nucleico, composição, tratamento, método
TW202005978A (zh) 2018-05-14 2020-02-01 美商拜奧馬林製藥公司 新穎肝靶向腺相關病毒載體
EP3980447A4 (en) * 2019-06-10 2023-07-26 Homology Medicines, Inc. ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR ARSA GENE TRANSFER AND METHODS OF USE THEREOF
TW202140791A (zh) * 2020-01-13 2021-11-01 美商霍蒙拉奇醫藥公司 治療苯酮尿症之方法
IL294713A (en) * 2020-01-16 2022-09-01 Takeda Pharmaceuticals Co Adeno associated virus based gene therapy for phenylketonuria
TW202208632A (zh) 2020-05-27 2022-03-01 美商同源醫藥公司 用於恢復pah基因功能的腺相關病毒組成物及其使用方法
CN116656740A (zh) * 2023-05-30 2023-08-29 浙江大学 一种腺相关病毒基因治疗载体及其在制备治疗苯丙酮尿症的药物中的应用
CN119876192B (zh) * 2024-07-02 2025-11-07 浙江大学滨江研究院 用于治疗苯丙酮尿症的多核苷酸

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198620A1 (en) 2002-04-16 2003-10-23 Keiya Ozawa Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
AU2003237159A1 (en) * 2002-04-30 2003-11-17 University Of Florida Treatment for phenylketonuria
WO2010124180A1 (en) * 2009-04-23 2010-10-28 Phasebio Pharmaceuticals, Inc. Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
US9839696B2 (en) * 2010-04-30 2017-12-12 City Of Hope Recombinant adeno-associated vectors for targeted treatment
DK2675902T3 (da) * 2011-02-17 2019-06-03 Univ Pennsylvania Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel
EA034103B1 (ru) * 2013-10-22 2019-12-27 Транслейт Био, Инк. СПОСОБ ЛЕЧЕНИЯ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
BR112017005892A2 (pt) * 2014-09-24 2017-12-12 Hope City variantes de vetor de vírus adeno-associado para edição de genoma de alta eficácia e métodos da mesma
KR102738752B1 (ko) * 2016-12-30 2024-12-06 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 페닐케톤뇨증을 치료하기 위한 유전자 치료

Similar Documents

Publication Publication Date Title
JP2021512601A5 (https=)
US12534717B2 (en) AAV capsid proteins for nucleic acid transfer
IL276215B2 (en) Adeno-associated virus compositions for pah gene transfer and methods of use thereof
ES3050313T3 (en) Liver-specific tropism of adeno-associated viruses
JP2020522269A5 (https=)
US8906387B2 (en) In vivo transduction with a chimeric AAV capsid protein
US11938197B2 (en) Polynucleotides and vectors for the expression of transgenes
US7427396B2 (en) AAV vectors for gene delivery to the lung
HRP20241180T1 (hr) Modificirani faktor ix, te pripravci, postupci i upotreba za prijenos gena u stanice, organe i tkiva
JP2012521750A5 (https=)
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
JP2018522529A5 (https=)
HRP20250897T1 (hr) Genska terapija za neurodegenerativne poremećaje
RU2017125234A (ru) Конструкции нуклеиновой кислоты и векторы для генотерапии для применения для лечения болезни вильсона и других состояний
JP2019528793A5 (https=)
JP2017529395A5 (https=)
JPWO2019152841A5 (https=)
JPWO2020186150A5 (https=)
JPWO2021243364A5 (https=)
TW202328451A (zh) 工程化itr序列及使用之方法
CN118103393A (zh) 工程化的itr序列及其使用方法
RU2018117179A (ru) Печень-специфичные конструкции, экспрессионные кассеты фактора viii и способы их применения
HK40044351B (en) Liver-specific tropism of adeno-associated viruses
RU2022123359A (ru) Новые капсидные белки аденоассоциированного вируса
NZ724165B2 (en) Compositions useful in treatment of ornithine transcarbamylase (otc) deficiency